The poster says the reported nausea and vomiting rates look far lower than for retatrutide, semaglutide or tirzepatide, and calls that suspicious. An opinion, not a finding.
Recap by typeshit. Post by @JCanNuSH on X.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A TriNetX study of 4,253 matched patients per group, shown at ACG 2026, found roughly half the MACE risk at one year with resmetirom. Retrospective data, so no causation.
Therapist Zoë Bisbing and novelist Rainbow Rowell describe moms on Ozempic-style drugs pushing daughters to start, and the body-image fights that follow.
Loading…